Abiopharma

🔍 Glavin Martin G (Executive)

Company: LAKELAND INDUSTRIES INC (LAKE)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 7,009 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: false | shares_owned_after: 30,167.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,103 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: false | shares_owned_after: 32,270.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The reporting person was granted restricted stock in lieu of a portion of his retainer fees for the remainder of the fiscal year ending January 31, 2027. The reporting person elected to receive $67,500 of his remaining fiscal year 2027 retainer fees in the form of the Issuer's common stock, par value $0.01 per share ("Common Stock"). The number of shares of restricted stock granted is based on a per share value of $9.63, the closing price of the Common Stock on the date of grant. The restricted stock vests on the first anniversary of the date of grant; provided, that the reporting person's service as a director is not terminated for cause prior to the vesting date.
• F2: The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock. These RSUs represent a 30% premium on the amount of retainer fees the reporting person has elected to receive in the form of equity in lieu of cash, as explained in the first footnote above. The number of RSUs granted is based on a per share value of $9.63, the closing price of the Common Stock on the date of grant. The RSUs vest on the first anniversary of the date of grant; provided, that the reporting person remains in continuous service through the vesting date.
• REMARKS: Exhibit 24 - Power of Attorney